JP2021532742A5 - - Google Patents
Info
- Publication number
- JP2021532742A5 JP2021532742A5 JP2021504286A JP2021504286A JP2021532742A5 JP 2021532742 A5 JP2021532742 A5 JP 2021532742A5 JP 2021504286 A JP2021504286 A JP 2021504286A JP 2021504286 A JP2021504286 A JP 2021504286A JP 2021532742 A5 JP2021532742 A5 JP 2021532742A5
- Authority
- JP
- Japan
- Prior art keywords
- nef
- domain
- tcr
- cells
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2018/097235 | 2018-07-26 | ||
| CN2018097235 | 2018-07-26 | ||
| PCT/CN2019/097969 WO2020020359A1 (en) | 2018-07-26 | 2019-07-26 | Nef-containing t cells and methods of producing thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021532742A JP2021532742A (ja) | 2021-12-02 |
| JP2021532742A5 true JP2021532742A5 (enExample) | 2022-07-06 |
Family
ID=69181353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021504286A Pending JP2021532742A (ja) | 2018-07-26 | 2019-07-26 | Ｎｅｆを含むｔ細胞及びその生成方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220177524A1 (enExample) |
| EP (1) | EP3827075A4 (enExample) |
| JP (1) | JP2021532742A (enExample) |
| KR (1) | KR20210049806A (enExample) |
| CN (2) | CN112771154B (enExample) |
| AU (1) | AU2019312411A1 (enExample) |
| CA (1) | CA3103337A1 (enExample) |
| IL (1) | IL280240A (enExample) |
| MX (1) | MX2021000934A (enExample) |
| SG (1) | SG11202012253WA (enExample) |
| TW (1) | TW202020146A (enExample) |
| WO (1) | WO2020020359A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9273283B2 (en) * | 2009-10-29 | 2016-03-01 | The Trustees Of Dartmouth College | Method of producing T cell receptor-deficient T cells expressing a chimeric receptor |
| IL296319A (en) * | 2020-03-09 | 2022-11-01 | Janssen Biotech Inc | Compositions and Methods for Quantifying Recombinant Vector Nucleic Acid Incorporation |
| WO2022116086A1 (en) * | 2020-12-03 | 2022-06-09 | Janssen Biotech, Inc. | Bcma-targeted car-t cell therapy for multiple myeloma |
| WO2022161502A1 (zh) * | 2021-02-01 | 2022-08-04 | 羿尊生物医药（浙江）有限公司 | 一种靶向蛋白降解系统及其应用 |
| WO2022198027A1 (en) * | 2021-03-18 | 2022-09-22 | The Wistar Institute Of Anatomy And Biology | DNA-ENCODED BISPECIFIC ANTIBODIES TARGETING IL13Rα2 AND METHODS OF USE IN CANCER THERAPEUTICS |
| KR20240042483A (ko) * | 2021-07-30 | 2024-04-02 | 에쓰티 피에이치아이 테라퓨틱스 컴퍼니 리미티드 | 범용성 t 세포 및 이의 응용 |
| IL312602A (en) * | 2021-11-04 | 2024-07-01 | Janssen Biotech Inc | Bcma-targeted car-t cell therapy for multiple myeloma |
| WO2023077343A1 (en) * | 2021-11-04 | 2023-05-11 | Janssen Biotech, Inc. | Bcma-targeted car-t cell therapy for multiple myeloma |
| WO2024022509A1 (en) * | 2022-07-29 | 2024-02-01 | Nanjing Legend Biotech Co., Ltd. | Methods for promoting persistence of cell therapy |
| WO2024098037A1 (en) * | 2022-11-04 | 2024-05-10 | WUGEN, Inc. | Generation of cd3 expressing immune cells for use in conjunction with cd3 binding bispecific targeting agents |
| WO2024153211A1 (en) * | 2023-01-19 | 2024-07-25 | Nanjing Legend Biotech Co., Ltd. | Fusion polypeptides for targeted protein degradation and mehtods of use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2280074A3 (en) * | 2001-07-05 | 2011-06-22 | Novartis Vaccines and Diagnostics, Inc. | Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof |
| BRPI0514447B8 (pt) * | 2004-08-17 | 2021-05-25 | Centre Nat Rech Scient | uso da função imunosupressora de uma proteína acessória do vírus da imunodeficiência humana ou do símio para a preparação de uma vacina |
| US9273283B2 (en) * | 2009-10-29 | 2016-03-01 | The Trustees Of Dartmouth College | Method of producing T cell receptor-deficient T cells expressing a chimeric receptor |
| BR112014029417B1 (pt) * | 2012-05-25 | 2023-03-07 | Cellectis | Método ex vivo para a preparação de células t para imunoterapia |
| BR112016018100A2 (pt) * | 2014-02-07 | 2018-02-20 | Univ Mcmaster | acoplador antigênico de células t trifuncional, métodos e usos do mesmo |
| PL3134432T3 (pl) * | 2014-04-25 | 2020-10-19 | Bluebird Bio, Inc. | Promotor mnd chimeryczne receptory antygenowe |
| TWI755547B (zh) * | 2016-01-21 | 2022-02-21 | 美商輝瑞股份有限公司 | 靶向表皮生長因子受體變異體iii之嵌合型抗原受體 |
| US20190161530A1 (en) * | 2016-04-07 | 2019-05-30 | Bluebird Bio, Inc. | Chimeric antigen receptor t cell compositions |
| US20190309307A1 (en) * | 2016-09-14 | 2019-10-10 | Benitec Biopharma Limited | REAGENTS FOR PRODUCING T-CELLS WITH NON-FUNCTIONAL T-CELL RECEPTORS (TCRs) COMPOSITIONS COMPRISING SAME AND USE THEREOF |
| US12378297B2 (en) * | 2017-04-14 | 2025-08-05 | The General Hospital Corporation | Chimeric antigen receptor T cells targeting the tumor microenvironment |
| CN110520196A (zh) * | 2017-04-19 | 2019-11-29 | 艾洛基治疗公司 | 改进的t细胞组合物和方法 |
-
2019
- 2019-07-26 US US17/262,787 patent/US20220177524A1/en not_active Abandoned
- 2019-07-26 KR KR1020217005328A patent/KR20210049806A/ko not_active Withdrawn
- 2019-07-26 CA CA3103337A patent/CA3103337A1/en active Pending
- 2019-07-26 WO PCT/CN2019/097969 patent/WO2020020359A1/en not_active Ceased
- 2019-07-26 AU AU2019312411A patent/AU2019312411A1/en not_active Abandoned
- 2019-07-26 CN CN201980062656.7A patent/CN112771154B/zh active Active
- 2019-07-26 EP EP19841972.3A patent/EP3827075A4/en not_active Withdrawn
- 2019-07-26 JP JP2021504286A patent/JP2021532742A/ja active Pending
- 2019-07-26 MX MX2021000934A patent/MX2021000934A/es unknown
- 2019-07-26 TW TW108126647A patent/TW202020146A/zh unknown
- 2019-07-26 CN CN202411827547.9A patent/CN119661659A/zh not_active Withdrawn
- 2019-07-26 SG SG11202012253WA patent/SG11202012253WA/en unknown
-
2021
- 2021-01-18 IL IL280240A patent/IL280240A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021532742A5 (enExample) | ||
| JP2024518011A5 (enExample) | ||
| JP2024507996A5 (enExample) | ||
| US12570743B2 (en) | BCMA-targeting engineered immune cell and use thereof | |
| US20190023764A1 (en) | Car having replicated binding motifs in a co-stimulatory domain | |
| AU2021307614B2 (en) | Engineered immune cell for allotransplantation | |
| US11180553B2 (en) | Chimeric antigen receptor | |
| US20250213708A1 (en) | Chimeric transmembrane proteins and uses thereof | |
| AU2019288733A1 (en) | Chimeric transmembrane proteins and uses thereof | |
| JP7699154B2 (ja) | 腫瘍微小環境を逆転させる融合タンパク質及びその使用 | |
| JP2019525956A5 (enExample) | ||
| JP2021514631A5 (enExample) | ||
| CA3032054A1 (en) | Combination therapies of chimeric antigen receptors and pd-1 inhibitors | |
| CN114015656A (zh) | 用于同种异体移植的工程化免疫细胞 | |
| CN111542545A (zh) | Cd38定向嵌合抗原受体构建体 | |
| JP2024510900A5 (enExample) | ||
| KR20230137923A (ko) | 신규한 키메라 항원 수용체 및 이의 용도 | |
| WO2018045034A1 (en) | Chimeric antigen receptors having gitr intracellular domain as co-stimulatory domain | |
| TW202432833A (zh) | 新穎ｃｄ１９結合體、包含彼之ｃａｒ—ｔ構築體及其使用方法 | |
| CN117683139A (zh) | 组成型嵌合细胞因子受体及表达其的免疫细胞及应用 | |
| JP2022521278A5 (enExample) | ||
| TW202430565A (zh) | 包含與il18組合之新穎cd19結合體之car-t構築體及其使用方法 | |
| WO2024179620A2 (zh) | 耐免疫排斥的工程化细胞 | |
| JP2025506515A5 (enExample) | ||
| EP4653524A1 (en) | Function-enhanced cell therapy |